Why is MRNA Up Today?
About Moderna, Inc. Common Stock
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clin...
Overall Confidence: 60%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector: -2.1%
Market Comparison
🔔 Get MRNA Alerts
We'll notify you when MRNA's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
MRNA has moved more than 3.0% up on 63 occasions in the past year.
Frequently Asked Questions
Why is MRNA stock up today?
This stock is significantly outperforming its BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector peers, suggesting a stock-specific catalyst.
Is MRNA stock a buy or sell right now?
Based on current analysis, MRNA shows 60% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the MRNA stock price target?
MRNA is currently trading at $195.89. Based on today's momentum, the expected short-term range is $191.97 - $201.76. See long-term price prediction →
Will MRNA stock continue rising?
Our analysis shows a 45% probability that MRNA's move continues in the next 1-3 days. Key level to watch: $205.68 (resistance).
Is MRNA stock oversold or overbought?
MRNA's RSI (Relative Strength Index) is currently at 63.6. This shows bullish momentum - the stock has positive momentum but isn't overextended yet.
What is the momentum for MRNA stock?
MRNA's 10-day momentum indicator is at 14.37. Strong bullish momentum - the stock is gaining significant upward force. This often precedes continued gains.
Is MRNA outperforming or underperforming the market?
MRNA (+4.49%) is currently significantly outperforming the market (+4.7% vs SPY). Today, the S&P 500 (SPY) is down -0.24%, and Nasdaq (QQQ) is down -0.25%.
What does MACD indicate for MRNA?
MRNA's MACD (17.9) is currently below the signal line (19.18), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 61.9) is strong.
Is MRNA in an uptrend or downtrend?
Based on moving average analysis, MRNA is in a bullish trend. The price ($195.89) is trading above both the 20-day SMA ($175.97) and 50-day SMA ($132.07). This alignment typically indicates sustained upward momentum.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis